Henseler M, Klein A, Reber M, Vanier M T, Landrieu P, Sandhoff K
Institut für Organische Chemie und Biochemie, Universität Bonn, Germany.
Am J Hum Genet. 1996 Jan;58(1):65-74.
Sphingolipid activator proteins (SAPs) are small, nonenzymatic glycoproteins required for the lysosomal degradation of various sphingolipids with a short oligosaccharide chain by their exohydrolases. Four of the five known activator proteins (sap-A-sap-D), also called "saposins," are derived from a common precursor by proteolytic processing. sap-B stimulates hydrolysis of sulfatides by arylsulfatase A in vivo. Its recessively inherited deficiency results in a metabolic disorder similar to classical metachromatic leukodystrophy, which is caused by a defect of arylsulfatase A. Here we report on a patient with sap-B deficiency. Reverse-transcription-PCR studies on the patient's mRNA revealed the occurrence of two distinct mutant species: one with an in-frame deletion of the first 21 bases of exon 6, the other with a complete in-frame deletion of this exon. The patient was homozygous for the underlying mutation, which was found to be a G-->T transversion within the acceptor splice site between intron e and exon 6, abolishing normal RNA splicing. Allele-specific oligonucleotide hybridization revealed that the parents and both grandfathers of the patient were carriers of this mutation. In order to analyze the fate of the mutant precursor proteins, both abnormal cDNAs were stably expressed in baby hamster kidney cells. Pulse-chase experiments showed that the deletion of 21 bp had no effect on the transport and the maturation of the encoded precursor. All sap forms except sap-B were detectable by immunochemical methods. The cDNA bearing a complete deletion of exon 6 encoded a shortened precursor of only 60 kD, and no mature SAPs were detectable. The carbohydrate chains of this polypeptide were of the high-mannose and hybrid type, indicating no transport of the mutant precursor beyond early Golgi apparatus. An endoplasmic-reticulum localization of this polypeptide was supported by indirect immunofluorescence analysis.
鞘脂激活蛋白(SAPs)是一种小分子非酶糖蛋白,是溶酶体通过外切水解酶对各种带有短寡糖链的鞘脂进行降解所必需的。已知的五种激活蛋白中的四种(sap - A至sap - D),也称为“鞘脂激活蛋白原”,是通过蛋白水解加工从一个共同的前体衍生而来。sap - B在体内刺激芳基硫酸酯酶A对硫脂的水解。其隐性遗传缺陷导致一种类似于经典异染性脑白质营养不良的代谢紊乱,后者是由芳基硫酸酯酶A的缺陷引起的。在此,我们报告一例sap - B缺乏症患者。对该患者mRNA进行的逆转录 - PCR研究揭示了两种不同突变体的存在:一种是外显子6的前21个碱基发生框内缺失,另一种是该外显子完全框内缺失。该患者为潜在突变的纯合子,该突变被发现是内含子e与外显子6之间的剪接受体位点处的G→T颠换,导致正常RNA剪接缺失。等位基因特异性寡核苷酸杂交显示,该患者的父母和两位祖父均为该突变的携带者。为了分析突变前体蛋白的命运,将两种异常cDNA在幼仓鼠肾细胞中稳定表达。脉冲追踪实验表明,21 bp的缺失对编码前体的转运和成熟没有影响。通过免疫化学方法可检测到除sap - B外的所有sap形式。外显子6完全缺失的cDNA编码一种仅60 kD的缩短前体,未检测到成熟的SAPs。该多肽的糖链为高甘露糖型和杂合型,表明突变前体未转运至高尔基体早期以外。间接免疫荧光分析支持该多肽定位于内质网。